ID

41369

Description

Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. See https://clinicaltrials.gov/ct2/show/NCT00039858 This Form has to be filled in at the screening visit. Section Pre-Treatment Anticoagulation has to be filled in within 96 hours prior to treatment initiation and additionally, if Heparin was administered, ACT or aPTT have to be measured before Heparin administration. Section Samples for Pre-Treatment PK and Confirmatory HIT Testing, Indication for Argatroban Use has to be filled in within 96 hours before treatment initiation administration. Section Indication for Argatroban Use records the indications on behalf of which is the medicament administered.

Link

https://clinicaltrials.gov/ct2/show/NCT00039858

Keywords

Versions (1)
  1. 9/14/20 9/14/20 -
Copyright Holder

GlaxoSmithKline

Uploaded on

September 14, 2020

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858

English

Anticoagulation, Samples for Pre-Treatment PK and Confirmatory HIT Testing, Indication for Argatroban Use

1 forms  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Site #
Description

Study centre number

Data type

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Patient #
Description

patient ID

Data type

integer

Alias
UMLS CUI [1]
C2348585
Visit Date
Description

visit date

Data type

date

Alias
UMLS CUI [1]
C1320303
Investigator Name
Description

Investigator Name

Data type

text

Alias
UMLS CUI [1]
C2826892
Pre-Treatment Anticoagulation
Description

Pre-Treatment Anticoagulation

Alias
UMLS CUI-1
C0003281
UMLS CUI-2
C0332152
UMLS CUI-3
C2347804
Was heparin being administered prior to study Argatroban administration?
Description

*If Yes, ACT or aPTT results must be from BEFORE heparin was administered. **If No, ACT or aPTT results must be completed up to 96 hours prior to treatment initiation. In either case, PT/INR results must be completed within 96 hours before treatment initiation.

Data type

text

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4684789
Laboratory Name:
Description

(Lab name must match name on lab normals.)

Data type

text

Alias
UMLS CUI [1]
C3258037
Check to indicate copy of associated lab report is attached to CRF.
Description

Is a copy of the lab report attached?

Data type

boolean

Alias
UMLS CUI [1,1]
C0684224
UMLS CUI [1,2]
C0587081
aPPT
Description

(check if test performed)

Data type

boolean

Alias
UMLS CUI [1]
C0030605
aPPT - Date
Description

(dd-mmm-yyyy)

Data type

date

Alias
UMLS CUI [1,1]
C0030605
UMLS CUI [1,2]
C2985720
aPPT - Time
Description

(0000-2359)

Data type

time

Alias
UMLS CUI [1,1]
C0030605
UMLS CUI [1,2]
C1516048
UMLS CUI [1,3]
C0040223
aPTT - Result
Description

(numeric value only)

Data type

float

Alias
UMLS CUI [1,1]
C0030605
UMLS CUI [1,2]
C0587081
aPTT - Clinically Significant
Description

aPTT - clinical significance

Data type

text

Alias
UMLS CUI [1,1]
C0030605
UMLS CUI [1,2]
C2826293
aPTT - If clinically significant, please comment
Description

aPPT - comment on clinical significance

Data type

text

Alias
UMLS CUI [1,1]
C1846819
UMLS CUI [1,2]
C0947611
UMLS CUI [1,3]
C2826293
PT or INR
Description

(check which test was performed)

Data type

text

Alias
UMLS CUI [1]
C0033707
UMLS CUI [2]
C0525032
PT or INR - Date
Description

(dd-mmm-yyyy)

Data type

date

Alias
UMLS CUI [1,1]
C0033707
UMLS CUI [1,2]
C2985720
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C2985720
PT or INR - Time
Description

(0000-2359)

Data type

time

Alias
UMLS CUI [1,1]
C0033707
UMLS CUI [1,2]
C1516048
UMLS CUI [1,3]
C0040223
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C1516048
UMLS CUI [2,3]
C0040223
PT or INR - Result
Description

(numeric value only)

Data type

float

Alias
UMLS CUI [1,1]
C0033707
UMLS CUI [1,2]
C0587081
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C0587081
PT or INR - Clinically Significant
Description

PT - clinical significance | INR - clinical significance

Data type

text

Alias
UMLS CUI [1,1]
C0033707
UMLS CUI [1,2]
C2826293
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C2826293
PT or INR - If clinically significant, please comment
Description

PT - comment on clinical significance | INR - comment on clinical significance

Data type

text

Alias
UMLS CUI [1,1]
C0033707
UMLS CUI [1,2]
C0947611
UMLS CUI [1,3]
C2826293
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C0947611
UMLS CUI [2,3]
C2826293
ACT
Description

(check if test performed)

Data type

boolean

Alias
UMLS CUI [1]
C0427611
ACT - Date
Description

(dd-mmm-yyyy)

Data type

date

Alias
UMLS CUI [1,1]
C0427611
UMLS CUI [1,2]
C2985720
ACT - Time
Description

(0000-2359)

Data type

time

Alias
UMLS CUI [1,1]
C0427611
UMLS CUI [1,2]
C1516048
UMLS CUI [1,3]
C0040223
ACT - Result
Description

(numeric value only)

Data type

float

Alias
UMLS CUI [1,1]
C0427611
UMLS CUI [1,2]
C0587081
ACT - Clinically Significant
Description

ACT - clinical significance

Data type

text

Alias
UMLS CUI [1,1]
C0427611
UMLS CUI [1,2]
C2826293
ACT - If clinically significant, please comment
Description

ACT - comment on clinical significance

Data type

text

Alias
UMLS CUI [1,1]
C0427611
UMLS CUI [1,2]
C0947611
UMLS CUI [1,3]
C2826293
Samples for Pre-Treatment PK and Confirmatory HIT Testing
Description

Samples for Pre-Treatment PK and Confirmatory HIT Testing

Alias
UMLS CUI-1
C0200345
UMLS CUI-2
C0031328
UMLS CUI-3
C0919799
Pre-treatment PK sample collected?
Description

Pharmacokinetic sample collection pre-treatment

Data type

text

Alias
UMLS CUI [1,1]
C0200345
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C2709094
*Date Collected:
Description

(dd-mmm-yyyy)

Data type

date

Alias
UMLS CUI [1,1]
C1302413
UMLS CUI [1,2]
C0031328
*Time Collected:
Description

(0000-2359)

Data type

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0200345
UMLS CUI [1,3]
C0031328
*Check to indicate PK sample sent to GSK
Description

Pharmacokinetic sample sent to sponsor

Data type

boolean

Alias
UMLS CUI [1,1]
C2347796
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C0370003
UMLS CUI [1,4]
C1515023
Confirmatory HIT testing sample collected (only if “Yes” was answered for Inclusion Criteria 2a, 2b, or 2c)?
Description

Confirmatory HIT testing sample collection

Data type

text

Alias
UMLS CUI [1,1]
C0200345
UMLS CUI [1,2]
C0919799
UMLS CUI [1,3]
C0750484
*Date Collected:
Description

(dd-mmm-yyyy)

Data type

date

Alias
UMLS CUI [1,1]
C1302413
UMLS CUI [1,2]
C0919799
*Time Collected:
Description

(0000-2359)

Data type

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0200345
UMLS CUI [1,3]
C0919799
*Check to indicate confirmatory HIT sample sent to central lab
Description

HIT testing sample sent to central lab

Data type

boolean

Alias
UMLS CUI [1,1]
C1880016
UMLS CUI [1,2]
C0919799
UMLS CUI [1,3]
C0370003
UMLS CUI [1,4]
C1515023
Indication for Argatroban Use
Description

Indication for Argatroban Use

Alias
UMLS CUI-1
C3146298
UMLS CUI-2
C0048470
Cardiac catherization
Description

Cardiac catherization

Data type

boolean

Alias
UMLS CUI [1]
C0018795
Cardiac surgery
Description

Cardiac surgery

Data type

boolean

Alias
UMLS CUI [1]
C0018821
VAD
Description

Artificial ventricle

Data type

boolean

Alias
UMLS CUI [1]
C0085842
ECMO
Description

ECMO

Data type

boolean

Alias
UMLS CUI [1]
C0015357
Hemodialysis
Description

Hemodialysis

Data type

boolean

Alias
UMLS CUI [1]
C0019004
CVVH
Description

CVVH

Data type

boolean

Alias
UMLS CUI [1]
C0472684
Clinical condition requiring continuous infusion therapy
Description

Clinical condition requiring continuous infusion therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C1511497
Other
Description

Other clinical condition

Data type

boolean

Alias
UMLS CUI [1]
C3843040
Other, specify:
Description

Other clinical condition - specify

Data type

text

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1521902
Back to the top of the page

Similar models

Anticoagulation, Samples for Pre-Treatment PK and Confirmatory HIT Testing, Indication for Argatroban Use

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Study centre number
Item
Site #
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
patient ID
Item
Patient #
integer
C2348585 (UMLS CUI [1])
visit date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Investigator Name
Item
Investigator Name
text
C2826892 (UMLS CUI [1])
Item Group
Pre-Treatment Anticoagulation
C0003281 (UMLS CUI-1)
C0332152 (UMLS CUI-2)
C2347804 (UMLS CUI-3)
Item
Was heparin being administered prior to study Argatroban administration?
text
C0019134 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4684789 (UMLS CUI [1,3])
Heparin administered prior to study
Code List
Was heparin being administered prior to study Argatroban administration?
CL Item
Yes* (Yes*)
CL Item
No** (No**)
Laboratory Name
Item
Laboratory Name:
text
C3258037 (UMLS CUI [1])
Is a copy of the lab report attached?
Item
Check to indicate copy of associated lab report is attached to CRF.
boolean
C0684224 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
aPPT
Item
aPPT
boolean
C0030605 (UMLS CUI [1])
aPPT - Assessment Date
Item
aPPT - Date
date
C0030605 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
aPPT - Assessment Time
Item
aPPT - Time
time
C0030605 (UMLS CUI [1,1])
C1516048 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
aPTT - test result
Item
aPTT - Result
float
C0030605 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Item
aPTT - Clinically Significant
text
C0030605 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
aPTT - clinical significance
Code List
aPTT - Clinically Significant
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
NA (NA)
aPPT - comment on clinical significance
Item
aPTT - If clinically significant, please comment
text
C1846819 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
Item
PT or INR
text
C0033707 (UMLS CUI [1])
C0525032 (UMLS CUI [2])
PT | INR
Code List
PT or INR
CL Item
PT (PT)
CL Item
INR (INR)
PT - Assessment Date | INR - Assessment Date
Item
PT or INR - Date
date
C0033707 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
C0525032 (UMLS CUI [2,1])
C2985720 (UMLS CUI [2,2])
PT - Assessment Time | INR - Assessment Time
Item
PT or INR - Time
time
C0033707 (UMLS CUI [1,1])
C1516048 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0525032 (UMLS CUI [2,1])
C1516048 (UMLS CUI [2,2])
C0040223 (UMLS CUI [2,3])
PT - test result | INR - test result
Item
PT or INR - Result
float
C0033707 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
C0525032 (UMLS CUI [2,1])
C0587081 (UMLS CUI [2,2])
Item
PT or INR - Clinically Significant
text
C0033707 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0525032 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
aPTT - clinical significance
Code List
PT or INR - Clinically Significant
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
NA (NA)
PT - comment on clinical significance | INR - comment on clinical significance
Item
PT or INR - If clinically significant, please comment
text
C0033707 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0525032 (UMLS CUI [2,1])
C0947611 (UMLS CUI [2,2])
C2826293 (UMLS CUI [2,3])
ACT
Item
ACT
boolean
C0427611 (UMLS CUI [1])
ACT - Assessment Date
Item
ACT - Date
date
C0427611 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
ACT - Assessment Time
Item
ACT - Time
time
C0427611 (UMLS CUI [1,1])
C1516048 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
ACT - test result
Item
ACT - Result
float
C0427611 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Item
ACT - Clinically Significant
text
C0427611 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
aPTT - clinical significance
Code List
ACT - Clinically Significant
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
NA (NA)
ACT - comment on clinical significance
Item
ACT - If clinically significant, please comment
text
C0427611 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
Item Group
Samples for Pre-Treatment PK and Confirmatory HIT Testing
C0200345 (UMLS CUI-1)
C0031328 (UMLS CUI-2)
C0919799 (UMLS CUI-3)
Item
Pre-treatment PK sample collected?
text
C0200345 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C2709094 (UMLS CUI [1,3])
Pharmacokinetic sample collection
Code List
Pre-treatment PK sample collected?
CL Item
Yes* (Yes*)
CL Item
No (No)
Pharmacokinetic sample collection date
Item
*Date Collected:
date
C1302413 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
Pharmacokinetic sample collection time
Item
*Time Collected:
time
C0040223 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0031328 (UMLS CUI [1,3])
Pharmacokinetic sample sent to sponsor
Item
*Check to indicate PK sample sent to GSK
boolean
C2347796 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C1515023 (UMLS CUI [1,4])
Item
Confirmatory HIT testing sample collected (only if “Yes” was answered for Inclusion Criteria 2a, 2b, or 2c)?
text
C0200345 (UMLS CUI [1,1])
C0919799 (UMLS CUI [1,2])
C0750484 (UMLS CUI [1,3])
Pharmacokinetic sample collection
Code List
Confirmatory HIT testing sample collected (only if “Yes” was answered for Inclusion Criteria 2a, 2b, or 2c)?
CL Item
Yes* (Yes*)
CL Item
No (No)
CL Item
N/A (N/A)
HIT testing sample collection date
Item
*Date Collected:
date
C1302413 (UMLS CUI [1,1])
C0919799 (UMLS CUI [1,2])
HIT testing sample collection time
Item
*Time Collected:
time
C0040223 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0919799 (UMLS CUI [1,3])
HIT testing sample sent to central lab
Item
*Check to indicate confirmatory HIT sample sent to central lab
boolean
C1880016 (UMLS CUI [1,1])
C0919799 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C1515023 (UMLS CUI [1,4])
Item Group
Indication for Argatroban Use
C3146298 (UMLS CUI-1)
C0048470 (UMLS CUI-2)
Cardiac catherization
Item
Cardiac catherization
boolean
C0018795 (UMLS CUI [1])
Cardiac surgery
Item
Cardiac surgery
boolean
C0018821 (UMLS CUI [1])
Artificial ventricle
Item
VAD
boolean
C0085842 (UMLS CUI [1])
ECMO
Item
ECMO
boolean
C0015357 (UMLS CUI [1])
Hemodialysis
Item
Hemodialysis
boolean
C0019004 (UMLS CUI [1])
CVVH
Item
CVVH
boolean
C0472684 (UMLS CUI [1])
Clinical condition requiring continuous infusion therapy
Item
Clinical condition requiring continuous infusion therapy
boolean
C0348080 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1511497 (UMLS CUI [1,3])
Other clinical condition
Item
Other
boolean
C3843040 (UMLS CUI [1])
Other clinical condition - specify
Item
Other, specify:
text
C3843040 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial